These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 17611774)

  • 41. Mutation analysis of the genes involved in the Ras-mitogen-activated protein kinase (MAPK) pathway in Korean patients with Noonan syndrome.
    Lee ST; Ki CS; Lee HJ
    Clin Genet; 2007 Aug; 72(2):150-5. PubMed ID: 17661820
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Noonan syndrome and its related disorders.
    Fukushima Y
    Acta Paediatr Jpn; 1996 Feb; 38(1):102-4. PubMed ID: 8992851
    [TBL] [Abstract][Full Text] [Related]  

  • 43. De novo HRAS and KRAS mutations in two siblings with short stature and neuro-cardio-facio-cutaneous features.
    Søvik O; Schubbert S; Houge G; Steine SJ; Norgård G; Engelsen B; Njølstad PR; Shannon K; Molven A
    J Med Genet; 2007 Jul; 44(7):e84. PubMed ID: 17601930
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [RAS/MAPK signal transduction pathway and its role in the pathogenesis of Noonan syndrome].
    Gos M; Leszkiewicz M; Abramowicz A
    Postepy Biochem; 2012; 58(3):255-64. PubMed ID: 23373411
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Biochemical characterization of novel germline BRAF and MEK mutations in cardio-facio-cutaneous syndrome.
    Rodriguez-Viciana P; Rauen KA
    Methods Enzymol; 2008; 438():277-89. PubMed ID: 18413255
    [TBL] [Abstract][Full Text] [Related]  

  • 46. RASopathies.
    Jafry M; Sidbury R
    Clin Dermatol; 2020; 38(4):455-461. PubMed ID: 32972603
    [TBL] [Abstract][Full Text] [Related]  

  • 47. HRAS and the Costello syndrome.
    Rauen KA
    Clin Genet; 2007 Feb; 71(2):101-8. PubMed ID: 17250658
    [TBL] [Abstract][Full Text] [Related]  

  • 48. An unexpected new role of mutant Ras: perturbation of human embryonic development.
    Kratz CP; Niemeyer CM; Zenker M
    J Mol Med (Berl); 2007 Mar; 85(3):227-35. PubMed ID: 17211612
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Novel BRAF mutation in a patient with LEOPARD syndrome and normal intelligence.
    Koudova M; Seemanova E; Zenker M
    Eur J Med Genet; 2009; 52(5):337-40. PubMed ID: 19416762
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Absence of PTPN11 mutations in 28 cases of cardiofaciocutaneous (CFC) syndrome.
    Ion A; Tartaglia M; Song X; Kalidas K; van der Burgt I; Shaw AC; Ming JE; Zampino G; Zackai EH; Dean JC; Somer M; Parenti G; Crosby AH; Patton MA; Gelb BD; Jeffery S
    Hum Genet; 2002 Oct; 111(4-5):421-7. PubMed ID: 12384786
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Craniofacial and cutaneous findings in Noonan, Costello and LEOPARD syndromes.
    Pokrowiecki R; Chomik P; Borowiec M; Dowgierd K; Starzyńska A
    Postepy Dermatol Alergol; 2018 Oct; 35(5):437-441. PubMed ID: 30429698
    [TBL] [Abstract][Full Text] [Related]  

  • 52. The RASopathies: developmental syndromes of Ras/MAPK pathway dysregulation.
    Tidyman WE; Rauen KA
    Curr Opin Genet Dev; 2009 Jun; 19(3):230-6. PubMed ID: 19467855
    [TBL] [Abstract][Full Text] [Related]  

  • 53. RAS-MAPK pathway disorders: important causes of congenital heart disease, feeding difficulties, developmental delay and short stature.
    Wright EM; Kerr B
    Arch Dis Child; 2010 Sep; 95(9):724-30. PubMed ID: 20371595
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Update on the treatment of RASopathies].
    Duat-Rodriguez A; Hernandez-Martin A
    Rev Neurol; 2017 May; 64(s03):S13-S17. PubMed ID: 28524213
    [TBL] [Abstract][Full Text] [Related]  

  • 55. No reason yet to change diagnostic criteria for Noonan, Costello and cardio-facio-cutaneous syndromes.
    Neri G; Allanson J; Kavamura MI
    J Med Genet; 2008 Dec; 45(12):832. PubMed ID: 19047498
    [No Abstract]   [Full Text] [Related]  

  • 56. Clinical and molecular analysis of RASopathies in a group of Turkish patients.
    Şimşek-Kiper PÖ; Alanay Y; Gülhan B; Lissewski C; Türkyilmaz D; Alehan D; Cetin M; Utine GE; Zenker M; Boduroğlu K
    Clin Genet; 2013 Feb; 83(2):181-6. PubMed ID: 22420426
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Germline KRAS mutations cause Noonan syndrome.
    Schubbert S; Zenker M; Rowe SL; Böll S; Klein C; Bollag G; van der Burgt I; Musante L; Kalscheuer V; Wehner LE; Nguyen H; West B; Zhang KY; Sistermans E; Rauch A; Niemeyer CM; Shannon K; Kratz CP
    Nat Genet; 2006 Mar; 38(3):331-6. PubMed ID: 16474405
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Expanding the genetic spectrum of Noonan syndrome.
    Noordam K
    Horm Res; 2007; 68 Suppl 5():24-7. PubMed ID: 18174700
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Molecular screening strategies for NF1-like syndromes with café-au-lait macules (Review).
    Zhang J; Li M; Yao Z
    Mol Med Rep; 2016 Nov; 14(5):4023-4029. PubMed ID: 27666661
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The RASopathies.
    Rauen KA
    Annu Rev Genomics Hum Genet; 2013; 14():355-69. PubMed ID: 23875798
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.